U.S. Energy Services Stock News

If you are wondering whether NetApp's current share price still offers value, it is essential to look past the headlines and into how the market is actually pricing the business. NetApp's stock recently closed at US$99.03, with returns of a 1.5% decline over 7 days, 2.8% over 30 days, a 7.0% decline year to date, 5.6% over 1 year, 61.7% over 3 years, and 78.1% over 5 years. Recent news has focused on NetApp's position in data storage and cloud-related solutions, with investors weighing how...

Conference spotlight and business mix overview Rambus (RMBS) is set to present at the Morgan Stanley Technology, Media & Telecom Conference on March 2, an opportunity for management to outline how its AI focused memory and licensing businesses fit together. The company now leans on a product centric semiconductor model built around DDR5 memory interface chips that serve AI server bandwidth needs, alongside a licensing engine that generates high margin royalties from long term agreements with...

NVIDIA (NVDA) just reported record quarterly and full year results with strong revenue, net income and guidance, yet the stock dropped over 5% as investors questioned how long AI spending can stay this intense. See our latest analysis for NVIDIA. That post earnings drop fits into a broader cooling in short term momentum, with a 1 day share price return of 4.16% decline, 7 day return of 7.50% decline and 30 day return of 7.29% decline. This comes even as the 1 year total shareholder return...

In late February 2026, BioCryst Pharmaceuticals reported fourth-quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, capping its first full year of profitability with US$874.84 million in revenue and US$263.86 million in net income. The move into sustained profitability, underpinned by strong ORLADEYO performance and the Astria Therapeutics acquisition that broadened its hereditary angioedema portfolio, marks a step-change in BioCryst’s financial and competitive...

Ziff Davis (ZD) shares were in focus after the company released fourth quarter and full year 2025 results, reporting steady annual sales alongside much weaker profitability and providing an update on its multi year share repurchase program. See our latest analysis for Ziff Davis. The earnings update, together with the multi year buyback reducing share count, comes after a sharp 30 day share price return decline of 29.15% and a 1 year total shareholder return decline of 32.20%, signaling...

Teleflex (TFX) is back in focus after reporting a fourth quarter net loss of US$714.3 million, missing Wall Street’s revenue and earnings expectations and issuing full year guidance below analyst estimates. See our latest analysis for Teleflex. The earnings miss and cautious outlook sit against a mixed share price picture, with a 16.95% one-month share price return and 7.98% seven-day move contrasting with a one-year total shareholder return decline of 8.67% and deeper three- and five-year...

In late February 2026, Coursera reported quarterly results showing stronger consumer segment performance alongside a softer enterprise environment, and issued revenue growth guidance for 2026 that was above prior market expectations. The combination of outperformance in consumer learning and a more upbeat revenue outlook, despite enterprise softness, has sharpened investor focus on how Coursera balances its two core segments. Now we’ll assess how Coursera’s above-consensus 2026 revenue...

If you are wondering whether Adobe's current share price lines up with its underlying worth, this article will walk through what the numbers are actually saying about value. Adobe closed at US$262.41, with returns of 6.4% over the last 7 days, a 10.5% decline over 30 days, a 21.3% decline year to date, a 40.5% decline over 1 year, a 24.4% decline over 3 years, and a 37.7% decline over 5 years. These moves have kept valuation firmly in focus for many investors, who are weighing whether the...

If you are wondering whether United Parcel Service (UPS) looks like good value right now, it helps to step back from the headline share price and look at what the numbers actually suggest about the business. UPS shares last closed at US$115.96, with returns of 0.8% over 7 days, 9.2% over 30 days, 14.8% year to date, 3.9% over 1 year, a 27.2% decline over 3 years and a 10.7% decline over 5 years. Taken together, this gives you a mixed picture of recent and longer term performance. Recent...

Ericsson and Intel (INTC) just expanded their long running partnership at Mobile World Congress 2026, teaming up on AI native 6G networks that combine advanced compute, cloud technologies, and real time sensing. See our latest analysis for Intel. Intel’s shares have been volatile around AI related headlines, but the 15.82% year to date share price return alongside a 100.57% one year total shareholder return suggests momentum is still broadly building despite recent pullbacks. If Ericsson’s 6G...

In February 2026, Rackspace Technology reported fourth quarter 2025 revenue of US$682.8 million and a net loss of US$32.7 million, alongside full-year 2025 revenue of US$2.69 billion and a net loss of US$225.8 million, both narrower than the prior year. The company also issued 2026 revenue guidance of US$2.60 billion to US$2.70 billion, giving investors a clearer view of expected top-line stability while losses remain material. Next, we will examine how Rackspace’s narrower 2025 net loss and...

If you are wondering whether GE Vernova’s current share price reflects its real worth, you are not alone. The stock has quickly become a focus for valuation minded investors. The shares last closed at US$873.60, with returns of 5.0% over the past 7 days, 20.3% over the past 30 days, 28.6% year to date and 177.1% over the past year. This naturally raises questions about how much future performance is already priced in. Recent news coverage has largely centred on GE Vernova’s position as a...

Ichor Holdings recently reported fourth-quarter 2025 results that beat earnings expectations and slightly topped revenue forecasts, while also issuing strong revenue guidance for the first quarter of 2026 that analysts received positively. Alongside these results, the company’s renewed emphasis on operational discipline, margin improvement, and core semiconductor relationships under new leadership is reinforcing confidence in its turnaround efforts. Now we’ll examine how this earnings beat...

Tootsie Roll Industries (TR) is back in focus after reporting full year 2025 results, with revenue of US$732.52 million and net income of US$100.05 million, along with an affirmed quarterly dividend. See our latest analysis for Tootsie Roll Industries. The earnings and dividend news arrives after a steady run in the shares, with a 30-day share price return of 11.48% and a year to date share price return of 19.26%. The 1-year total shareholder return of 38.24% and 5-year total shareholder...

If you are wondering whether Meta Platforms is still attractively priced after its big run over the last few years, starting with the valuation basics can help you decide how it fits in your portfolio. At a last close of US$648.18, the stock has seen a 1.1% decline over the last 7 days and a 9.5% decline over the last 30 days, while the 3 year return of 252.3% and 5 year return of 147.0% show how different timeframes can tell very different stories. Recent headlines have continued to focus...

In February 2026, PT Pertamina (Persero) announced it had signed a memorandum of understanding with Halliburton to accelerate advanced well construction, hydraulic fracturing, acid stimulation, and digital drilling technologies in selected onshore fields across Indonesia. This collaboration highlights Halliburton’s push to pair unconventional completion expertise with closed-loop automation and artificial intelligence, deepening its role in technology-intensive international projects. Next,...

Pediatrix Medical Group (MD) has drawn investor attention after recent share performance, with the stock down about 7% over the past month and 17% over the past 3 months, despite positive 1 year and 3 year total returns. See our latest analysis for Pediatrix Medical Group. The recent 7% 1 month and 17% 3 month share price declines suggest fading near term momentum, even though the 1 year and 3 year total shareholder returns remain positive. This can reflect investors reassessing Pediatrix...

Houlihan Lokey filed an SEC prospectus supplement covering the resale of new Class A shares tied to recent acquisitions and performance milestones. The filing sets out how these newly issued shares can be resold by certain holders, clarifying the legal status of stock linked to completed deals. The move sheds light on how Houlihan Lokey structures equity based incentives for acquired teams and deal related performance. For you as an investor looking at NYSE:HLI, this filing provides an...

In February 2026, Western Midstream Partners reported fourth-quarter 2025 results that increased revenue to US$1,031.48 million but saw net income fall to US$187.18 million, while issuing 2026 guidance that includes adjusted EBITDA of US$2.5–2.7 billion and lower capital spending of US$850 million to US$1 billion. Alongside these results, the partnership raised its 2026 distribution guidance to at least US$3.70 per unit, including a planned quarterly increase to US$0.93 per unit starting...

Amentum Holdings (AMTM) has been attracting fresh attention after securing a contract to support the UK Ministry of Defence’s hypersonic weapons program, along with roughly US$1b in nuclear sector awards in FQ1 2026. See our latest analysis for Amentum Holdings. Amentum’s recent client wins in hypersonics and nuclear awards arrive after a mixed stretch for the stock, with a 16.5% 1 month share price decline but a 62% 1 year total shareholder return from today’s US$29.87 level. If this defence...

Belite Bio (BLTE) shares are under the spotlight after the company reported a fourth quarter net loss of US$25.32 million and a full year net loss of US$77.61 million, both above prior-year levels. See our latest analysis for Belite Bio. Despite the wider losses, Belite Bio’s share price has shown strong momentum, with a 26.16% 90 day share price return and a very large 1 year total shareholder return that sits near 5x. This may point to shifting expectations around its pipeline rather than...

Why S&P Global (SPGI) is on investors’ radar today S&P Global (SPGI) has drawn attention after recent trading left the stock with a mixed return profile, including negative moves over the past month and past 3 months despite longer term gains. See our latest analysis for S&P Global. At a share price of US$441.88, S&P Global has recently seen a 9.17% 7 day share price return after a weaker patch that included a 16.28% 30 day share price decline and a 15.86% 1 year total shareholder return...

Lucid Group (LCID) has come under fresh scrutiny after reporting a wider fourth quarter 2025 loss, workforce cuts of 12% in its U.S. salaried staff, and revised 2025 production figures. See our latest analysis for Lucid Group. The earnings miss, production revision and workforce cuts have coincided with a 1 year total shareholder return decline of 52.83% and a 3 year total shareholder return decline of 88.66%. The 90 day share price return decline of 22.36% suggests selling pressure has been...

In recent months, several law firms have filed securities class action lawsuits against Varonis Systems, alleging the company misled investors about its ability to convert customers to its SaaS platform and sustain ARR growth between February 4, 2025 and October 28, 2025. This legal pressure highlights a tension between the bullish long-term thesis on Varonis’ role in data-centric cybersecurity and fresh questions about the reliability of its past growth disclosures. We'll now examine how...